Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fulminant hepatic failure

J L Riegler1, J R Lake

  • 1Department of Medicine, University of California, San Francisco.

The Medical Clinics of North America
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Fulminant hepatic failure (FHF) is a severe condition often caused by viral infections. Liver transplantation offers improved survival rates, with ongoing research into new techniques and therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OPTN/SRTR 2020 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2022
Same author

OPTN/SRTR 2019 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2021
Same author

The Impact of Tenofovir Disoproxil Fumarate on Reduced Bone Mineral Density and Fractures in Liver Transplant Recipients.

Transplantation proceedings·2020
Same author

OPTN/SRTR 2018 Annual Data Report: Hepatitis C.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2020
Same author

OPTN/SRTR 2018 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2020
Same author

OPTN/SRTR 2017 Annual Data Report: Liver.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2019
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Area of Science:

  • Hepatology
  • Transplantation Medicine
  • Virology

Background:

  • Fulminant hepatic failure (FHF) is a rare but severe condition with high morbidity and mortality.
  • Viral infections are the most common cause, though drugs and metabolic disorders also contribute.
  • Emerging diagnostic tools like PCR may enhance understanding of FHF's causes and pathogenesis.

Purpose of the Study:

  • To outline current medical management strategies for FHF.
  • To review the role and advancements in liver transplantation for FHF.
  • To discuss ongoing research in FHF therapies.

Main Methods:

  • Review of current medical literature and clinical practices for FHF management.
  • Analysis of outcomes and challenges associated with liver transplantation (OLT) for FHF.

Related Experiment Videos

  • Discussion of novel therapeutic approaches and transplantation techniques.

    • Main Results:

    • Medical management focuses on preventing and treating systemic complications.
    • Liver transplantation has significantly improved FHF patient outlook, with survival rates between 55% and 75%.
    • Challenges include organ allocation and timely transplantation.

    Conclusions:

    • Early consultation with transplant centers is crucial for patients with FHF.
    • Liver transplantation is a life-saving option for FHF, with survival rates improving.
    • Innovations in transplantation, such as heterotopic and living donor transplants, hold promise for better outcomes.